vs

Side-by-side financial comparison of IDACORP INC (IDA) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

IDACORP INC is the larger business by last-quarter revenue ($360.1M vs $321.1M, roughly 1.1× MADRIGAL PHARMACEUTICALS, INC.). IDACORP INC runs the higher net margin — 12.1% vs -18.2%, a 30.4% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs -4.2%). MADRIGAL PHARMACEUTICALS, INC. produced more free cash flow last quarter ($-133.8M vs $-216.2M).

IDACORP, Inc is an electricity holding company, incorporated in Idaho with headquarters in Boise. It comprises Idaho Power Company, IDACORP Financial and Ida-West Energy. It was formed on October 1, 1998.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

IDA vs MDGL — Head-to-Head

Bigger by revenue
IDA
IDA
1.1× larger
IDA
$360.1M
$321.1M
MDGL
Growing faster (revenue YoY)
MDGL
MDGL
+215.0% gap
MDGL
210.8%
-4.2%
IDA
Higher net margin
IDA
IDA
30.4% more per $
IDA
12.1%
-18.2%
MDGL
More free cash flow
MDGL
MDGL
$82.4M more FCF
MDGL
$-133.8M
$-216.2M
IDA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IDA
IDA
MDGL
MDGL
Revenue
$360.1M
$321.1M
Net Profit
$43.6M
$-58.6M
Gross Margin
Operating Margin
14.9%
-18.6%
Net Margin
12.1%
-18.2%
Revenue YoY
-4.2%
210.8%
Net Profit YoY
15.1%
1.4%
EPS (diluted)
$0.78
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDA
IDA
MDGL
MDGL
Q4 25
$360.1M
$321.1M
Q3 25
$526.4M
$287.3M
Q2 25
$449.3M
$212.8M
Q1 25
$411.1M
$137.3M
Q4 24
$375.9M
$103.3M
Q3 24
$532.5M
$62.2M
Q2 24
$442.6M
Q1 24
$417.9M
$0
Net Profit
IDA
IDA
MDGL
MDGL
Q4 25
$43.6M
$-58.6M
Q3 25
$124.4M
$-114.2M
Q2 25
$95.8M
$-42.3M
Q1 25
$59.6M
$-73.2M
Q4 24
$37.9M
$-59.4M
Q3 24
$113.6M
$-107.0M
Q2 24
$89.5M
Q1 24
$48.2M
$-147.5M
Gross Margin
IDA
IDA
MDGL
MDGL
Q4 25
Q3 25
Q2 25
Q1 25
96.7%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
IDA
IDA
MDGL
MDGL
Q4 25
14.9%
-18.6%
Q3 25
27.5%
-39.7%
Q2 25
22.4%
-22.2%
Q1 25
13.4%
-57.8%
Q4 24
11.0%
-64.8%
Q3 24
25.1%
-187.1%
Q2 24
23.3%
Q1 24
11.9%
Net Margin
IDA
IDA
MDGL
MDGL
Q4 25
12.1%
-18.2%
Q3 25
23.6%
-39.8%
Q2 25
21.3%
-19.9%
Q1 25
14.5%
-53.4%
Q4 24
10.1%
-57.5%
Q3 24
21.3%
-172.0%
Q2 24
20.2%
Q1 24
11.5%
EPS (diluted)
IDA
IDA
MDGL
MDGL
Q4 25
$0.78
$-2.55
Q3 25
$2.26
$-5.08
Q2 25
$1.76
$-1.90
Q1 25
$1.10
$-3.32
Q4 24
$0.72
$-2.50
Q3 24
$2.12
$-4.92
Q2 24
$1.71
Q1 24
$0.95
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDA
IDA
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$215.7M
$198.7M
Total DebtLower is stronger
$3.3B
$339.9M
Stockholders' EquityBook value
$3.6B
$602.7M
Total Assets
$10.2B
$1.3B
Debt / EquityLower = less leverage
0.93×
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDA
IDA
MDGL
MDGL
Q4 25
$215.7M
$198.7M
Q3 25
$333.2M
$295.7M
Q2 25
$474.5M
$186.2M
Q1 25
$634.5M
$183.6M
Q4 24
$368.9M
$100.0M
Q3 24
$427.9M
$232.7M
Q2 24
$169.6M
Q1 24
$157.6M
$622.5M
Total Debt
IDA
IDA
MDGL
MDGL
Q4 25
$3.3B
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$3.1B
$117.6M
Q3 24
$117.1M
Q2 24
Q1 24
$116.1M
Stockholders' Equity
IDA
IDA
MDGL
MDGL
Q4 25
$3.6B
$602.7M
Q3 25
$3.5B
$625.7M
Q2 25
$3.4B
$696.0M
Q1 25
$3.3B
$710.6M
Q4 24
$3.3B
$754.4M
Q3 24
$3.3B
$777.2M
Q2 24
$3.2B
Q1 24
$2.9B
$850.8M
Total Assets
IDA
IDA
MDGL
MDGL
Q4 25
$10.2B
$1.3B
Q3 25
$10.1B
$1.4B
Q2 25
$9.9B
$1.0B
Q1 25
$9.6B
$996.6M
Q4 24
$9.2B
$1.0B
Q3 24
$9.1B
$1.1B
Q2 24
$8.7B
Q1 24
$8.3B
$1.1B
Debt / Equity
IDA
IDA
MDGL
MDGL
Q4 25
0.93×
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.92×
0.16×
Q3 24
0.15×
Q2 24
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDA
IDA
MDGL
MDGL
Operating Cash FlowLast quarter
$137.8M
$-133.5M
Free Cash FlowOCF − Capex
$-216.2M
$-133.8M
FCF MarginFCF / Revenue
-60.0%
-41.7%
Capex IntensityCapex / Revenue
98.3%
0.1%
Cash ConversionOCF / Net Profit
3.16×
TTM Free Cash FlowTrailing 4 quarters
$-577.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDA
IDA
MDGL
MDGL
Q4 25
$137.8M
$-133.5M
Q3 25
$162.8M
$79.8M
Q2 25
$176.9M
$-47.1M
Q1 25
$124.3M
$-88.9M
Q4 24
$136.4M
$-104.5M
Q3 24
$201.9M
$-67.0M
Q2 24
$146.4M
Q1 24
$109.7M
$-149.2M
Free Cash Flow
IDA
IDA
MDGL
MDGL
Q4 25
$-216.2M
$-133.8M
Q3 25
$-127.9M
$79.0M
Q2 25
$-156.4M
Q1 25
$-77.0M
Q4 24
$-48.9M
$-104.7M
Q3 24
$-16.1M
$-67.8M
Q2 24
$-199.6M
Q1 24
$-150.3M
$-149.5M
FCF Margin
IDA
IDA
MDGL
MDGL
Q4 25
-60.0%
-41.7%
Q3 25
-24.3%
27.5%
Q2 25
-34.8%
Q1 25
-18.7%
Q4 24
-13.0%
-101.3%
Q3 24
-3.0%
-109.0%
Q2 24
-45.1%
Q1 24
-36.0%
Capex Intensity
IDA
IDA
MDGL
MDGL
Q4 25
98.3%
0.1%
Q3 25
55.2%
0.3%
Q2 25
74.2%
0.0%
Q1 25
49.0%
0.0%
Q4 24
49.3%
0.2%
Q3 24
41.0%
1.3%
Q2 24
78.2%
Q1 24
62.2%
Cash Conversion
IDA
IDA
MDGL
MDGL
Q4 25
3.16×
Q3 25
1.31×
Q2 25
1.85×
Q1 25
2.08×
Q4 24
3.60×
Q3 24
1.78×
Q2 24
1.63×
Q1 24
2.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IDA
IDA

Retailrevenues$323.0M90%
Transmissionserviceswheeling$18.6M5%
Energyefficiencyprogramrevenues$11.7M3%
Wholesaleenergysales$10.5M3%
Otherrevenues$9.5M3%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons